Financials

  • Market Capitalization 409.41 M
  • Employee 59
  • Founded 2017
  • CEO N/A
  • Website www.lexeotx.com
  • Headquarter New York, United States
  • FIGI BBG00YB1C8M5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3052
GALT
Galectin Therapeutics Inc. - Common Stock
4.14 USD-0.24%+14.36%+20.70%-1.43%417.52 M USD
3062
FENC
Fennec Pharmaceuticals Inc. - Common Stock
11.77 USD-3.29%+2.62%+17.00%+31.36%412.74 M USD
3074
IPSC
Century Therapeutics, Inc. - Common Stock
2.23 USD+4.21%+8.78%+9.31%+337.25%403.80 M USD
3077
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.80 USD-2.47%+3.99%+9.87%+58.80%401.93 M USD

Frequently asked questions about Lexeo Therapeutics, Inc. Common Stock

What is the Lexeo Therapeutics, Inc. Common Stock stock price today?

The current price of Lexeo Therapeutics, Inc. Common Stock (LXEO) is 4.99. Over the past 24 hours, the stock has changed by -0.40%. Follow the LXEO chart for real-time price dynamics.

What is the stock ticker of Lexeo Therapeutics, Inc. Common Stock?

Lexeo Therapeutics, Inc. Common Stock trades under the ticker LXEO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Lexeo Therapeutics, Inc. Common Stock stock going up?

LXEO has changed by -2.54% over the last week, +13.67% over the last month, and +3.74% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Lexeo Therapeutics, Inc. Common Stock?

Lexeo Therapeutics, Inc. Common Stock currently has a market capitalization of 409.41 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Lexeo Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Lexeo Therapeutics, Inc. Common Stock reported earnings of -0.3 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Lexeo Therapeutics, Inc. Common Stock net income for the last quarter?

Lexeo Therapeutics, Inc. Common Stock reported net income of -25.87 M for the last quarter. The previous quarter showed -20.2 M, which means net income changed by -28.08%.

How many employees does Lexeo Therapeutics, Inc. Common Stock have?

As of the latest available data, Lexeo Therapeutics, Inc. Common Stock has 59 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Lexeo Therapeutics, Inc. Common Stock stock?

You can buy Lexeo Therapeutics, Inc. Common Stock (LXEO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Lexeo Therapeutics, Inc. Common Stock stock?

Investing in Lexeo Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LXEO chart and related analysis on metatrader.com as part of your research.

News